Sheehan & Giddens Suicidality Phenomena Definitions
About the Sheehan & Giddens Suicidality Phenomena Definitions
Crosswalks to Other Nomenclature Systems
Mapping Tables to Assessment Scales and Structured Interviews
License Agreement for Use of the Sheehan & Giddens Suicidality Phenomena Definitions
Training for the Sheehan & Giddens Suicidality Phenomena Definitions
Translations and Linguistic Validation of the Sheehan & Giddens Suicidality Phenomena Definitions
How to Cite the Sheehan & Giddens Suicidality Phenomena Definitions
About the Sheehan & Giddens Suicidality Phenomena Definitions
The Sheehan and Giddens definitions were created to fix the issues present in the nomenclature systems of suicidality phenomena definitions currently available. While critically reviewing the nomenclature system in the United States Food and Drug Administration’s 2012 draft guidance for industry on the assessment of suicidal ideation and behavior in clinical trials, Sheehan & Giddens realized there were a number of instances of suicidality that would not meet the current definitions (a type 1 error) and there were instances where the definitions were unintentionally over-inclusive (a type II error). (For more information on this issue see chapter 12.2 of citation 2 in How to Cite the Sheehan & Giddens Suicidality Phenomena Definitions below and see Sheehan, D. V., Giddens, J. M., & Harnett-Sheehan, K. (2014). Current Assessment and Classification of Suicidal Phenomena using the FDA 2012 Draft Guidance Document on Suicide Assessment: A Critical Review. Innovations in clinical neuroscience, 11.) They felt it was important for proper definitions of suicidality phenomena to be available which corrected the issues found in this and other nomenclature systems.
For any scientific questions relating to the Sheehan & Giddens Phenotypic Suicidality Disorders Classification and Criteria, contact David V Sheehan MD MBA at davidVsheehan@gmail.com or Jennifer M Giddens at jennifermgiddens@gmail.com
Crosswalks to Other Nomenclature Systems
The products listed below are crosswalks between the Sheehan & Giddens suicidality phenomena definitions and the other major nomenclature systems currently in use. Each of the crosswalks contain the Sheehan & Giddens title and definition for a suicidality phenomenon, the title and definition used by the comparison nomenclature system, and an explanation of the differences between the titles or definitions for each system. They provide examples to show how the definitions in the contrasting systems, do or do not accommodate real world patient experiences.
Crosswalk Between Sheehan & Giddens Suicidality Phenomena Definitions and FDA-CASA 2012 (click here)
Crosswalk Between Sheehan & Giddens Suicidality Phenomena Definitions and C-CASA 2010 (click here)
Crosswalk Between Sheehan & Giddens Suicidality Phenomena Definitions and SDVCS MIRECC (click here)
Crosswalk Between Sheehan & Giddens Suicidality Phenomena Definitions and CDC-UD (click here)
Mapping Tables to Assessment Scales and Structured Interviews
The products listed below are mapping tables that show how various assessment scales and structured interviews map to and captures the Sheehan & Giddens suicidality phenomena definitions. Each of the mapping tables contain the Sheehan & Giddens title and how each scale or structured interview maps to or captures each of the suicidality phenomena. Many of the mapping tables are also scoring forms to document whether each of the suicidality phenomena occurred and the intensity / seriousness of each, if it occurred.
Suicide Plan Tracking Scale (SPTS) to Sheehan & Giddens Mapping Tables Scoring Forms (click here)
Suicidal Impulse Attack Scale (SIAS) to Sheehan & Giddens Mapping Tables Scoring Forms (click here)
Suicidality Modifiers Scale (SMS) to Sheehan & Giddens Mapping Tables Scoring Forms (click here)
The 6 mapping tables listed above have been merged into one overall mapping table to assist regulatory agencies and researchers in understanding how all of the scales / structured interviews capture each phenomenon.
Mapping Table of Scales to Sheehan & Giddens Suicidality Definitions (click here)
License Agreement for Use of the Sheehan & Giddens Suicidality Phenomena Definitions
Dr. Sheehan and Jennifer Giddens license the Sheehan & Giddens Suicidality Phenomena Definitions in paper format for distribution as follows : 1) in paper format for any uses; or 2) in fixed pdf form, paper form, or both for use in clinical or academic research trials or studies.
To license the Sheehan & Giddens Suicidality Phenomena Definitions for use there is a charge of $2 per use in a single administration (not per patient enrolled). The amount is payable in full before study initiation. For more information about licensing please email davidVsheehan@gmail.com
Training for the Sheehan & Giddens Suicidality Phenomena Definitions
For information about training on the Sheehan & Giddens Suicidality Phenomena Definitions, please contact davidVsheehan@gmail.com or jennifermgiddens@gmail.com Jennifer M. Giddens does not authorize anyone to provide training on her scales, structured interviews, or classifications who is not a licensed psychiatrist or clinical psychologist (MD or PhD) and who has not been specifically trained and authorized to provide this training by Jennifer M. Giddens.
Translations and Linguistic Validation of the Sheehan & Giddens Suicidality Phenomena Definitions
For information about translations of the Sheehan & Giddens Suicidality Phenomena Definitions, please contact: translations@harmresearch.org
How to Cite the Sheehan & Giddens Suicidality Phenomena Definitions
Use the following citations in referencing the Sheehan & Giddens Suicidality Phenomena Definitions:
1. Sheehan DV, Giddens JM. (2015). Suicidality: A Roadmap for Assessment and Treatment. (1st ed.). Tampa, FL: Harm Research Press. Nov. 2015 (Available from: https://HarmResearch.org) ISBN: 978-0-9969729-0-1
2. Sheehan DV, Giddens JM. (2016). Suicidality Assessment and Documentation for Healthcare Providers: A Brief, Practical Guide. (1st ed.). Tampa, FL: Harm Research Press. April 2016. (Available from: https://HarmResearch.org) ISBN: 978-0-9969729-1-8